ScholarLens Back to search
1946•BloodRequires access

ERYTHROBLASTOSIS FETALIS IN THE FIRST-BORN

Philip Levine, Robert K. Waller

Open publisher page 26 citations

Abstract

Abstract The incidence of fatal forms of erythroblastosis fetalis in the first-born can be diminished by the simple measure of transfusing all Rh negative female patients, even as infants, with Rh negative blood. Once a female patient is found to be Rh negative, all subsequent transfusions must be carried out with Rh negative blood. The indications are that sufficient human anti-Rh serums will become available for the more extensive Rh tests required for the prevention of iso-immunization by transfusion.

About this research paper

What this paper is about

Abstract The incidence of fatal forms of erythroblastosis fetalis in the first-born can be diminished by the simple measure of transfusing all Rh negative female patients, even as infants, with Rh negative blood. Once a female patient is found to be Rh negative, all subsequent transfusions must be carried out with Rh negative blood. The indications are that sufficient human anti-Rh serums will become available for the more extensive Rh tests required for the prevention of iso-immunization by transfusion.

Why it matters

OpenAlex reports 26 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Abstract The incidence of fatal forms of erythroblastosis fetalis in the first-born can be diminished by the simple measure of transfusing all Rh negative female patients, even as infants, with Rh negative blood. Once a female patient is found to be Rh negative, all subsequent transfusions must be carried out with Rh negative blood. The indications are that sufficient human anti-Rh serums will become available for the more extensive Rh tests required for the prevention of iso-immunization by transfusion.

Key concepts: Erythroblastosis fetalis, Medicine, Rh blood group system, Blood transfusion, Incidence (geometry), Pediatrics, Immunization, Isoantibodies

Related papers

Related paper 1Related paper 2
Back to paper searchBrowse research topicsOriginal source
ERYTHROBLASTOSIS FETALIS IN THE FIRST-BORN — Research Paper | ScholarLens